- Home
- ARRY vs INVA Comparison
ARRY vs INVA Comparison
Compare ARRY & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARRY
- INVA
- Stock Information
- Founded
- ARRY 1989
- INVA 1996
- Country
- ARRY United States
- INVA United States
- Employees
- ARRY N/A
- INVA N/A
- Industry
- ARRY Semiconductors
- INVA Biotechnology: Pharmaceutical Preparations
- Sector
- ARRY Technology
- INVA Health Care
- Exchange
- ARRY Nasdaq
- INVA Nasdaq
- Market Cap
- ARRY 1.0B
- INVA 1.2B
- IPO Year
- ARRY 2020
- INVA 2004
- Fundamental
- Price
- ARRY $5.86
- INVA $18.25
- Analyst Decision
- ARRY Buy
- INVA Buy
- Analyst Count
- ARRY 22
- INVA 1
- Target Price
- ARRY $12.61
- INVA N/A
- AVG Volume (30 Days)
- ARRY 5.5M
- INVA 684.8K
- Earning Date
- ARRY 11-07-2024
- INVA 11-06-2024
- Dividend Yield
- ARRY N/A
- INVA N/A
- EPS Growth
- ARRY N/A
- INVA 46.55
- EPS
- ARRY N/A
- INVA 0.99
- Revenue
- ARRY $982,190,000.00
- INVA $352,745,000.00
- Revenue This Year
- ARRY N/A
- INVA $16.20
- Revenue Next Year
- ARRY $23.78
- INVA N/A
- P/E Ratio
- ARRY N/A
- INVA $18.62
- Revenue Growth
- ARRY N/A
- INVA 21.46
- 52 Week Low
- ARRY $5.15
- INVA $14.33
- 52 Week High
- ARRY $18.92
- INVA $21.28
- Technical
- Relative Strength Index (RSI)
- ARRY 44.50
- INVA 34.59
- Support Level
- ARRY $5.15
- INVA $18.33
- Resistance Level
- ARRY $6.19
- INVA $18.69
- Average True Range (ATR)
- ARRY 0.38
- INVA 0.33
- MACD
- ARRY -0.07
- INVA -0.05
- Stochastic Oscillator
- ARRY 28.88
- INVA 13.61
About ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.